290 related articles for article (PubMed ID: 19464594)
1. Melanoma genetics: an update on risk-associated genes.
Udayakumar D; Tsao H
Hematol Oncol Clin North Am; 2009 Jun; 23(3):415-29, vii. PubMed ID: 19464594
[TBL] [Abstract][Full Text] [Related]
2. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Pho L; Grossman D; Leachman SA
Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
[TBL] [Abstract][Full Text] [Related]
3. Melanoma and genetics.
Nelson AA; Tsao H
Clin Dermatol; 2009; 27(1):46-52. PubMed ID: 19095153
[TBL] [Abstract][Full Text] [Related]
4. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
Begg CB; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Mitra N; Busam K; From L; Berwick M;
J Natl Cancer Inst; 2005 Oct; 97(20):1507-15. PubMed ID: 16234564
[TBL] [Abstract][Full Text] [Related]
5. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
[TBL] [Abstract][Full Text] [Related]
6. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
[TBL] [Abstract][Full Text] [Related]
7. High- and low-penetrance cutaneous melanoma susceptibility genes.
Fargnoli MC; Argenziano G; Zalaudek I; Peris K
Expert Rev Anticancer Ther; 2006 May; 6(5):657-70. PubMed ID: 16759158
[TBL] [Abstract][Full Text] [Related]
8. Toward a molecular classification of melanoma.
Fecher LA; Cummings SD; Keefe MJ; Alani RM
J Clin Oncol; 2007 Apr; 25(12):1606-20. PubMed ID: 17443002
[TBL] [Abstract][Full Text] [Related]
9. Genetics in melanoma.
Stahl S; Bar-Meir E; Friedman E; Regev E; Orenstein A; Winkler E
Isr Med Assoc J; 2004 Dec; 6(12):774-7. PubMed ID: 15609895
[TBL] [Abstract][Full Text] [Related]
10. [Molecular biology of familial cases of human melanoma].
Kit OI; Vodolazhsky DL; Timoshkina NN; Przhedetsky YV; Khokhlova OV
Vopr Onkol; 2015; 61(6):889-97. PubMed ID: 26995975
[TBL] [Abstract][Full Text] [Related]
11. Management of familial melanoma and nonmelanoma skin cancer syndromes.
Santillan AA; Cherpelis BS; Glass LF; Sondak VK
Surg Oncol Clin N Am; 2009 Jan; 18(1):73-98, viii. PubMed ID: 19056043
[TBL] [Abstract][Full Text] [Related]
12. Hereditary cutaneous melanoma.
Platz A; Ringborg U; Hansson J
Semin Cancer Biol; 2000 Aug; 10(4):319-26. PubMed ID: 10966854
[TBL] [Abstract][Full Text] [Related]
13. Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.
Council ML; Gardner JM; Helms C; Liu Y; Cornelius LA; Bowcock AM
Exp Dermatol; 2009 May; 18(5):485-7. PubMed ID: 19320745
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor variants and the malignant melanoma risk: a population-based study.
Gapska P; Scott RJ; Serrano-Fernandez P; Mirecka A; Rassoud I; Górski B; Cybulski C; Huzarski T; Byrski T; Nagay L; Maleszka R; Sulikowski M; Lubinski J; Debniak T
Cancer Epidemiol; 2009 Aug; 33(2):103-7. PubMed ID: 19679055
[TBL] [Abstract][Full Text] [Related]
15. Confirmed cancer trends in families of patients with multiple cancers including cutaneous melanoma.
Nielsen K; Masback A; Bladstrom A; Lundgren L; Jonsson N; Borg A; Ingvar C; Olsson H
Br J Dermatol; 2008 Feb; 158(2):429-31. PubMed ID: 18047508
[No Abstract] [Full Text] [Related]
16. Genetics of melanoma susceptibility.
Ghiorzo P; Scarrà GB
Forum (Genova); 2003; 13(2):114-22; quiz 187. PubMed ID: 14732879
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
Nagore E; Montoro A; García-Casado Z; Botella-Estrada R; Insa A; Lluch A; López-Guerrero JA; Guillén C
Melanoma Res; 2009 Aug; 19(4):211-4. PubMed ID: 19571771
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic variation in familial melanoma: consequences for predictive DNA testing.
Bergman W; Gruis NA
Arch Dermatol; 2007 Apr; 143(4):525-6. PubMed ID: 17438187
[No Abstract] [Full Text] [Related]
19. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
Eliason MJ; Hansen CB; Hart M; Porter-Gill P; Chen W; Sturm RA; Bowen G; Florell SR; Harris RM; Cannon-Albright LA; Swinyer L; Leachman SA
Arch Dermatol; 2007 Nov; 143(11):1409-12. PubMed ID: 18025365
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
Berwick M; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Busam K; From L; Mujumdar U; Wilcox H; Begg CB;
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1520-5. PubMed ID: 16896043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
